Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methazolamide in open-angle glaucoma
NCT05498103Phase 4Active, not recruiting
- Sponsor
- University of Colorado Denver
- Start
- Feb 2023
- Primary completion
- Sep 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of methazolamide in Open-angle glaucoma (OAG), sponsored by University of Colorado Denver. Started Feb 2023; status: active, not recruiting.
02
Drugs
methazolamide
03
Conditions
Open-angle glaucoma (OAG)
Beyond the preview
Go deeper on NCT05498103.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05498103.